Obesity and dyslipidemia in patients with psoriasis treated at a dermatologic clinic in Manaus;Obesidade e dislipidemia em pacientes com psoríase atendidos num ambulatório de dermatologia de Manaus

Anais Brasileiros de Dermatologia

Volumn 88, Issue 6, 2013, Pages 913-916

  Santos, Mônica ^a   Fonseca, Hannah Monteiro ^a   Jalkh, Alex Panizza ^b   Gomes, Gabriela Piraice ^a   Cavalcante, Andrea de Souza ^b  

^a UNIVERSIDADE DO ESTADO DO AMAZONAS   (Brazil)

^b Tropical Medicine Foundation Dr Heitor Vieira Dourado   (Brazil)

Author keywords

Dyslipidemias; Obesity; Psoriasis

Indexed keywords

ADULT; AGED; ARTICLE; BODY HEIGHT; BODY MASS; CHOLESTEROL BLOOD LEVEL; DERMATOLOGICAL PROCEDURE; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; GENDER; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; PHYSICAL EXAMINATION; PREVALENCE; PROSPECTIVE STUDY; PSORIASIS; PSORIASIS VULGARIS; RISK ASSESSMENT; WAIST CIRCUMFERENCE; YOUNG ADULT;

ADULT; AGE DISTRIBUTION; AGED; BODY MASS INDEX; BRAZIL; COMORBIDITY; DYSLIPIDEMIAS; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; PREVALENCE; PROSPECTIVE STUDIES; PSORIASIS; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS; STATISTICS, NONPARAMETRIC; WAIST CIRCUMFERENCE;

EID: 84893082652     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/abd1806-4841.20132090     Document Type: Article

References (16)

1. Gudjonsson JE, Elder JT. Psoriasis: epidemiology. Clin Dermatol. 2007;25:535-46.
2. Nickoloff BJ, Qin JZ, Nestle FO. Immunopathogenesis of psoriasis. Clin Rev Allergy Immunol. 2007;33:45-56.
3. Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370:263-71.
4. Naldi L, Chatenoud L, Belloni A, Peserico A, Balato N, Virgili AR, et al. Medical history, drug exposure and the risk of psoriasis. Evidence from an Italian case-control study. Dermatology. 2008;216:125-30.
5. Lindegård B. Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes. Dermatologica. 1986;172:298-304.
6. Nijsten T, Wakkee M. Complexity of the association between psoriasis and comorbidities. J Invest Dermatol. 2009;129:1601-3.
7. Kimball AB, Wu Y. Cardiovascular disease and classic cardiovascular risk factors in patients with psoriasis. Int J Dermatol. 2009;48:1147-56.
8. Nisa N, Qazi MA. Prevalence of metabolic syndrome in patients with psoriasis. Indian J Dermatol Venereol Leprol. 2010;76:662-5.
9. Mebazaa A, El Asmi M, Zidi W, Zayani Y, Cheikh Rouhou R, El Ounifi S, et al. Metabolic syndrome in Tunisian psoriatic patients: prevalence and determinants. J Eur Acad Dermatol Venereol. 2011;25:705-9.
10. Mallbris L, Granath F, Hamsten A, Ståhle M. Psoriasis is associated with lipid abnormalities at the onset of skin disease. J Am Acad Dermatol. 2006;54:614-21.
11. Duarte GV, Follador I, Cavalheiro CM, Silva TS, Oliveira Mde F. Psoriasis and obesity: literature review and recommendations for management. An Bras Dermatol. 2010;85:355-60.
12. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet. 2005;366:1059-62.
13. Ribeiro Filho FF, Mariosa LS, Ferreira SR, Zanella MT. Visceral fat and metabolic syndrome: more than a simple association. Arq Bras Endocrinol Metabol. 2006;50:230-8.
14. Naldi L, Chatenoud L, Linder D, Belloni Fortina A, Peserico A, Virgili AR, et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: Results from an Italian case-control study. J Invest Dermatol. 2005;125:61-7.
15. Cohen AD, Gilutz H, Henkin Y, Zahger D, Shapiro J, Bonneh DY, et al. Psoriasis and the Metabolic Syndrome. Acta Derm Venereol. 2007;87:506-9.
16. Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res. 2006;298:321-8.